150 related articles for article (PubMed ID: 28098399)
1. MYB, CD117 and SOX-10 expression in cutaneous adnexal tumors.
Evangelista MT; North JP
J Cutan Pathol; 2017 May; 44(5):444-450. PubMed ID: 28098399
[TBL] [Abstract][Full Text] [Related]
2. GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms.
Pardal J; Sundram U; Selim MA; Hoang MP
Am J Dermatopathol; 2017 Apr; 39(4):279-286. PubMed ID: 28323779
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry for CD117 (KIT) is effective in distinguishing cutaneous adnexal tumors with apocrine/eccrine or sebaceous differentiation from other epithelial tumors of the skin.
Goto K
J Cutan Pathol; 2015 Jul; 42(7):480-8. PubMed ID: 25864700
[TBL] [Abstract][Full Text] [Related]
4. Sox10 and DOG1 Expression in Primary Adnexal Tumors of the Skin.
Lezcano C; Ho J; Seethala RR
Am J Dermatopathol; 2017 Dec; 39(12):896-902. PubMed ID: 28394798
[TBL] [Abstract][Full Text] [Related]
5. Magnifying glass on spiradenoma and cylindroma histogenesis and tumorigenesis using systematic transcriptome analysis.
Bell AH; Prieto VG; Ferrarotto R; Goepfert RP; Myers JN; Weber R; Bell D
Ann Diagn Pathol; 2019 Aug; 41():14-23. PubMed ID: 31128548
[TBL] [Abstract][Full Text] [Related]
6. Expression of Bcl-x in normal skin and benign cutaneous adnexal tumors.
Thamboo TP; Tan LH; Tan SY
J Cutan Pathol; 2006 Jan; 33(1):27-32. PubMed ID: 16441408
[TBL] [Abstract][Full Text] [Related]
7. Detection of MYB Alterations and Other Immunohistochemical Markers in Primary Cutaneous Adenoid Cystic Carcinoma.
North JP; McCalmont TH; Fehr A; van Zante A; Stenman G; LeBoit PE
Am J Surg Pathol; 2015 Oct; 39(10):1347-56. PubMed ID: 26076064
[TBL] [Abstract][Full Text] [Related]
8. SOX-10 expression in cutaneous myoepitheliomas and mixed tumors.
Naujokas A; Charli-Joseph Y; Ruben BS; Yeh I; LeBoit PE; McCalmont TH; Pincus LB
J Cutan Pathol; 2014 Apr; 41(4):353-63. PubMed ID: 24329979
[TBL] [Abstract][Full Text] [Related]
9. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.
Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP
Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821
[TBL] [Abstract][Full Text] [Related]
10. KIT (CD117) Expression in Benign and Malignant Sweat Gland Tumors.
Nishida H; Daa T; Kashima K; Arakane M; Urabe S; Yoshikawa Y; Gamachi A; Yokoyama S
Am J Dermatopathol; 2015 Dec; 37(12):898-905. PubMed ID: 25634571
[TBL] [Abstract][Full Text] [Related]
11. The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma.
Fehr A; Kovács A; Löning T; Frierson H; van den Oord J; Stenman G
J Pathol; 2011 Jul; 224(3):322-7. PubMed ID: 21618541
[TBL] [Abstract][Full Text] [Related]
12. p53 expression in sweat gland tumors.
Biernat W; Woźniak L
Pol J Pathol; 1996; 47(1):3-6. PubMed ID: 8705267
[TBL] [Abstract][Full Text] [Related]
13. Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: an immunohistochemical study with CD200 and other stem cell markers.
Sellheyer K
J Cutan Pathol; 2015 Feb; 42(2):90-101. PubMed ID: 25354097
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous adnexal carcinoma arising within a solitary cylindroma-spiradenoma.
Biernat W; Biernat S
Am J Dermatopathol; 1996 Feb; 18(1):77-82. PubMed ID: 8721596
[TBL] [Abstract][Full Text] [Related]
15. Spiradenoma With Adenoid Cystic Carcinoma-like Changes: A Case Series of This Rare Variant With a Potential Diagnostic Pitfall.
Plaza JA; Kastnerova L; Gru AA; Dulmage B; Sangueza MJ; Kazakov DV
Am J Surg Pathol; 2023 Dec; 47(12):1409-1416. PubMed ID: 37737683
[TBL] [Abstract][Full Text] [Related]
16. The expression of CD23 in cutaneous non-lymphoid neoplasms.
Carvalho J; Fullen D; Lowe L; Su L; Ma L
J Cutan Pathol; 2007 Sep; 34(9):693-8. PubMed ID: 17696916
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical studies of normal sweat glands, sweat gland tumors and extramammary Paget's diseases. II. Immunohistochemical studies of sweat gland tumors and extramammary Paget's diseases].
Ansai S
Nihon Hifuka Gakkai Zasshi; 1990 Feb; 100(2):133-46. PubMed ID: 2165191
[TBL] [Abstract][Full Text] [Related]
18. DF3 (CA15-3) antibody as a marker of cutaneous adnexal tumors.
Yasui S; Ando I; Kukita A; Hino H; Ohara K
Acta Derm Venereol; 1994 Mar; 74(2):98-100. PubMed ID: 7911637
[TBL] [Abstract][Full Text] [Related]
19. Low-grade adnexal carcinoma of the skin with multidirectional (glandular, trichoblastomatous, spiradenocylindromatous) differentiation.
Kazakov DV; Kutzner H; Mukensnabl P; Michal M
Am J Dermatopathol; 2006 Aug; 28(4):341-5. PubMed ID: 16871040
[TBL] [Abstract][Full Text] [Related]
20. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
Plaza JA; Ortega PF; Stockman DL; Suster S
J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
